{
  "ptid_time": "021_S_4659_2017-06-14",
  "img_path": "/data/qiuhui/data/adni/images/021_S_4659/2017-06-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 62,377 mm³, 27.6% above the reference mean. With a Z-score of 2.50 (99.4th percentile), this represents significant enlargement; hippocampal volume measures 5,980 mm³, 6.1% below the reference mean. With a Z-score of -0.67 (25.3th percentile), this represents normal volume ; whole brain volume measures 1,049,530 mm³, 4.8% above the reference mean. With a Z-score of 0.81 (79.2th percentile), this represents normal volume ; entorhinal cortex volume measures 3,732 mm³, 5.6% below the reference mean. With a Z-score of -0.29 (38.7th percentile), this represents normal volume ; fusiform gyrus volume measures 17,466 mm³, 3.6% above the reference mean. With a Z-score of 0.42 (66.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,400 mm³, 2.4% below the reference mean. With a Z-score of -0.37 (35.6th percentile), this represents normal volume . ",
  "text_data": "Age is 90.9 years. Gender is Male. Education: 17 years. MMSE: 24.0. MoCA: 17.0. Logical Memory: 8.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.59 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant ventricular enlargement (Z-score 2.50), which is often associated with brain atrophy, but hippocampal volume is only slightly reduced (Z-score -0.67). Cognitive testing (MMSE 24, MoCA 17) suggests mild impairment, and the presence of two APOE4 alleles along with profoundly elevated AV45 (amyloid PET) strongly indicates amyloid pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology given amyloid burden and APOE4 status).  \n\n**Confidence:** **High** (due to clear amyloid evidence and cognitive scores, though structural atrophy is not yet severe).",
  "timestamp": "2025-07-26T01:50:18.355239"
}